These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 4048012)

  • 21. Central antiserotonin action of amitriptyline.
    Maj J; Lewandowska A; Rawtów A
    Pharmakopsychiatr Neuropsychopharmakol; 1979 May; 12(3):281-5. PubMed ID: 314638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional interaction between serotonin-S2 and dopamine-D2 neurotransmission as revealed by selective antagonism of hyper-reactivity to tryptamine and apomorphine.
    Awouters F; Niemegeers CJ; Megens AA; Janssen PA
    J Pharmacol Exp Ther; 1990 Sep; 254(3):945-51. PubMed ID: 1697623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lack of antidepressant properties and a potent central antiserotonin activity of Org 8282.
    Przegaliński E; Baran L; Siwanowicz J; Rawłów A
    Pol J Pharmacol Pharm; 1986; 38(4):377-84. PubMed ID: 3774630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apomorphine hypothermia: interaction with serotonergic agents.
    Kulkarni SK
    Pol J Pharmacol Pharm; 1980; 32(1):15-20. PubMed ID: 7192860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central action of pirenzepine.
    Rogóz Z; Skuza G; Sowińska H
    Pol J Pharmacol Pharm; 1981; 33(6):615-26. PubMed ID: 6897118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central action of amitriptyline N-oxide.
    Maj J; Vetulani J; Michaluk J; Rogóz Z; Skuza G
    Pharmacopsychiatria; 1982 Nov; 15(6):187-91. PubMed ID: 6185962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the 5-HT3 receptor antagonist ondansetron on amphetamine-induced hyperactivity and stereotypy in rats.
    Shankar RP; Karan RS; Handu SS; Bhargava VK
    Indian J Physiol Pharmacol; 2000 Jul; 44(3):355-8. PubMed ID: 10941627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central beta- and alpha-adrenolytic activities of adimolol.
    Maj J; Klimek V; Lewandowska A; Zazula M
    Pol J Pharmacol Pharm; 1987; 39(1):81-90. PubMed ID: 2890141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone.
    Green AR; O'Shaughnessy K; Hammond M; Schächter M; Grahame-Smith DG
    Neuropharmacology; 1983 May; 22(5):573-8. PubMed ID: 6603593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central action of glaucine in rodents.
    Jagiełło-Wójtowicz E; Kleinrok Z; Jusiak L; Matuszek B; Daniłoś J; Chodakowska A
    Acta Pol Pharm; 1994; 51(2):179-84. PubMed ID: 7863789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
    Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
    Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amitriptyline and femoxetine, but not clomipramine or citalopram, antagonize hyperthermia induced by directly acting 5-hydroxytryptamine-like drugs in heat adapted rats.
    Pawłowski L
    J Pharm Pharmacol; 1984 Mar; 36(3):197-9. PubMed ID: 6144758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some central effects of opioid antagonists. Part I.
    Skorupska M; Langwiński R
    Pol J Pharmacol Pharm; 1989; 41(5):401-11. PubMed ID: 2577060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychopharmacological profile of dexamisole.
    Przegaliński E; Bigajska K; Siwanowicz J
    Pol J Pharmacol Pharm; 1980; 32(1):21-9. PubMed ID: 7454609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
    Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central action of phenylethylamine in rats.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1981; 33(1):59-71. PubMed ID: 7196039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
    Cohen ML; Fuller RW; Kurz KD; Parli CJ; Mason NR; Meyers DB; Smallwood JK; Toomey RE
    J Pharmacol Exp Ther; 1988 Jan; 244(1):106-12. PubMed ID: 3335993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the central antiserotonin activity of benzoctamine and opipramol.
    Przegaliński E; Baran L; Palider W; Bigajska K
    Pol J Pharmacol Pharm; 1978; 30(6):781-90. PubMed ID: 582625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central effects following repeated treatment with antidepressant drugs.
    Maj J
    Pol J Pharmacol Pharm; 1984; 36(2-3):87-99. PubMed ID: 6089162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
    Skuza G; Rogóz Z; Wieczorek A
    Pol J Pharmacol; 1997; 49(1):5-15. PubMed ID: 9431546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.